Active substance destroys cancer cells within an hour

Oleocanthal A in olive oil is believed to reduce growth, kill cancer cells, prevent 60% of tumor formation.

Discussing "Results of research on Oleocanthal active ingredients in killing cancer cells" in Hanoi on November 13, Professor John D. Sunal, American Biochemistry Research and Development Center (CSRD) for know, Oleocanthal A is the natural active ingredient found in pure. This is a substance with a strong anti-inflammatory effect.

Oleocanthal is considered to prevent diseases related to inflammatory and oxidative reactions, antibacterial, anti-cancer and neuroprotective. In particular, most of the studies on anti-cancer effects. Results of scientific studies, Oleocanthal A prevents malignant tumors, breast, liver and colon cancer cells.

Oleocanthal A in olive oil works to kill cancer cells.

This active ingredient is thought to only kill cancer cells, and good cells around it will temporarily stop functioning (sleeping peacefully) within 60 minutes, then survive and develop normally.

Professor John explained that compared with the body's cells, the cancer cells grew larger, the waste bags (the sacs) grew more, contained more waste than normal cells, thin cell membranes. Oleocanthal A active substance will come, attack and puncture the cancer cell's sac that causes death within 30 minutes to an hour. And the good cells do not bulge, the thick membrane, so this substance will not affect them.

For surgical patients, Oleocanthal A prevents the development of precancerous cells, blocks metastasis.

According to the Drug Administration of the Ministry of Health, further research is needed to develop Oleocanthal A. Currently, Oleocanthal is only extracted from olive fruit, has not been studied to develop into a cancer treatment.

According to Global Cancer Recognition (GLOBOCAL) and estimates of Vietnam Cancer Recognition, each year Vietnam has more than 126,000 new cases and about 94,000 deaths. According to WHO, the incidence of cancer in Vietnam today is 87.2 / 100,000 people.